SOPHiA GENETICS (SOPH) Non-Current Debt (2020 - 2025)
SOPHiA GENETICS (SOPH) reported Non-Current Debt of $47.7 million for Q4 2025, up 260.6% on a YoY basis from $13.2 million in Q4 2024, and little changed sequentially from $47.6 million in Q3 2025.
SOPHiA GENETICS (SOPH) Non-Current Debt (2020 - 2025) Analysis & Trends
SOPHiA GENETICS (SOPH) has 3 years of Non-Current Debt data on file, last reported at $47.7 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Debt rose 260.6% year-over-year to $47.7 million; the trailing twelve-month figure through Dec 2025 stood at $47.7 million (up 260.6% YoY), and the FY2025 full-year result was $47.7 million, up 260.6% from the prior year.
- Non-Current Debt held at $47.7 million in Q4 2025, from $47.6 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $47.7 million in Q4 2025 to a low of $13.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.78 Bn | 24.46 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.61 Bn | 13.71 Bn | 482.22 Mn | 2.44 Bn |
| 3 | Healthequity | 8.33 Bn | 8.06 Bn | 256.31 Mn | 942.66 Mn |
| 4 | Hinge Health | 5.94 Bn | 5.63 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.84 Bn | 5.30 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 1.46 Bn |
| 8 | Doximity | 3.94 Bn | 3.19 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.15 Bn | 2.73 Bn | - | - |
| 10 | SOPHiA GENETICS | 379.57 Mn | 309.28 Mn | 14.69 Mn | 47.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47.73 Mn |
| Sep 30, 2025 | 47.58 Mn |
| Jun 30, 2025 | 47.47 Mn |
| Mar 31, 2025 | 13.32 Mn |
| Dec 31, 2024 | 13.24 Mn |
| Sep 30, 2024 | 13.16 Mn |
| Jun 30, 2024 | 13.34 Mn |
| Dec 31, 2020 | 457,000.00 |